The US dietary supplements industry is only worth about $12 billion, according to Dr Kurt Jetta, CEO and founder of the TABS Group.
Third-party labs that keep their testing information proprietary to gain a competitive advantage may actually be harming their business, say leading experts calling for more transparency in the analytical sector.
Stepping beyond a company's in-house expertise and hooking into a provider of ingredient- and product-specific data can make R&D into more of a science and less of an art. Experts at Bulu Box, which generates data from its subscription-based supplements and foods sampling service, and Brandwatch, which helps companies monitor...
The world’s biggest clinical study on the immune effects of probiotics has found that the L. casei 431 strain could reduce the duration of symptoms from the common cold and flu – though no differences were found in the incidence or severity of illness.